GleamWall
中文EN

VNRX VOLITIONRX LTD

In Vitro & In Vivo Diagnostic Substances · NYSE · SEC CIK 93314 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY134.0%
TTM net income YoY-3.8%
TTM EPS YoY62.7%
Revenue 3-yr CAGR74.3%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-512.6%
Net margin-698.5%
FCF margin-597.6%
EBITDA margin-489.2%

Returns

ROE—
ROA-352.5%
ROIC (approx.)—
Asset turnover0.50x

Leverage & solvency

Liabilities / assets481.7%
Debt / equity—
Current ratio0.33x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.85x
Accruals ratio-51.9%
Payout ratio—
Capex / revenue2.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$1.73M$1.23M
R&D expense$10.08M$14.41M
SG&A expense$9.46M$8.49M
Operating income-$21.74M-$27.02M
Net income-$23.36M-$26.97M
EBITDA-$20.75M-$25.91M
EPS (diluted)—-0.31
Weighted avg. shares (diluted)106.83M86.53M
Balance sheet
Cash & equivalents$1.12M$3.26M
Receivables$317,808$110,574
Current assets$2.06M$4.06M
PP&E, net$4.03M$4.43M
Intangibles$316,704$313,747
Total assets$6.90M$9.40M
Current liabilities$12.23M$7.79M
Short-term debt$890,571$860,223
Long-term debt$5.82M$3.95M
Total debt$6.71M$4.81M
Total liabilities$42.49M$35.51M
Shareholders' equity-$34.25M-$24.91M
Net debt$5.59M$1.55M
Shares outstanding6.29M96.10M
Cash flow statement
Operating cash flow-$19.68M-$25.89M
Capital expenditure$89,558$277,499
Free cash flow-$19.77M-$26.17M
Investing cash flow-$89,558-$573,852
Financing cash flow$17.09M$8.66M
Depreciation & amortization$983,706$1.11M
Stock-based compensation$1.74M$1.27M
Share buybacks—$0

Free plan shows the latest 2 periods; Pro shows all 15 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.